Panbela Therapeutics (PBLA) Short Interest Ratio & Short Volume $0.28 -0.02 (-5.30%) As of 06/4/2025 12:36 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Short Interest DataPanbela Therapeutics (PBLA) has a short interest of 100 shares. This marks a -93.75% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 18,811 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest1,600 sharesChange Vs. Previous Month-93.75%Dollar Volume Sold Short$30.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2025Outstanding Shares4,855,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume8,762 sharesAverage Trading Volume18,811 sharesToday's Volume Vs. Average47% Short Selling Panbela Therapeutics? Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPBLA Short Interest Over TimePBLA Days to Cover Over TimePBLA Percentage of Float Shorted Over Time Panbela Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2025100 shares $30.00 -93.8%N/A0 $0.30 4/30/20251,600 shares $424.00 No ChangeN/A0.1 $0.27 4/15/2025100 shares $31.30 -66.7%N/A0 $0.31 3/14/2025300 shares $111.30 -95.5%N/A0 $0.37 2/14/2025300 shares $102.00 -25.0%N/A0 $0.34 1/31/2025400 shares $140.00 -94.0%N/A0 $0.35 1/15/20256,700 shares $2,814.00 +6,600.0%N/A0.1 $0.42 2/29/2024114,700 shares $135,346.00 +7.2%2.4%0.1 $1.18 2/15/2024107,000 shares $135,890.00 -39.8%2.2%0.1 $1.27 1/31/2024177,700 shares $247,003.00 +283.0%3.7%0.3 $1.39 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202446,400 shares $584,640.00 -96.6%9.7%0.2 $12.60 12/31/20231,350,000 shares $1.24 million +1,319.6%14.1%0.3 $0.92 12/15/202395,100 shares $43,470.21 +115.7%1.9%0 $0.46 11/30/202344,100 shares $23,373.00 -32.1%0.9%0 $0.53 11/15/202364,900 shares $39,134.70 -22.2%1.3%0.1 $0.60 10/31/202383,400 shares $66,903.48 +22.5%2.8%0.1 $0.80 10/15/202368,100 shares $70,143.00 -21.5%2.3%0.6 $1.03 9/30/202386,700 shares $113,577.00 -18.2%3.0%0.1 $1.31 9/15/2023106,000 shares $139,920.00 +26.6%3.6%0.1 $1.32 8/31/202383,700 shares $116,343.00 +335.9%2.9%0.1 $1.39 8/15/202319,200 shares $28,800.00 -60.5%0.7%0 $1.50 7/31/202348,600 shares $97,686.00 +102.5%1.7%0.1 $2.01 7/15/202324,000 shares $49,920.00 -74.6%0.9%0 $2.08 6/30/202394,600 shares $217,580.00 -50.3%3.4%0.4 $2.30 6/15/2023190,500 shares $1.11 million +590.2%6.9%0.9 $5.81 5/31/202327,600 shares $186,382.80 -96.3%5.1%0.2 $6.75 5/15/2023754,400 shares $309,304.00 -59.9%N/A0.3 $0.41 4/30/20231,880,000 shares $1.03 million -23.0%N/A0.6 $0.55 4/15/20232,440,000 shares $1.39 million +611.6%N/A0.9 $0.57 3/31/2023342,900 shares $151,630.38 +3.9%N/A0.1 $0.44 3/15/2023330,200 shares $219,549.98 -61.6%N/A0.2 $0.66 2/28/2023859,300 shares $1.18 million -18.2%13.7%0.5 $1.37 2/15/20231,050,000 shares $1.52 million +596.8%16.7%0.7 $1.45 1/31/2023150,700 shares $247,148.00 -63.9%2.5%0.1 $1.64 1/15/2023417,700 shares $1.39 million -67.4%55.4%1.2 $3.32 12/30/20221,280,000 shares $93,824.00 +60.5%N/A0.2 $0.07 12/15/2022797,500 shares $77,357.50 +227.1%N/A0.2 $0.10 11/30/2022243,800 shares $33,010.52 +354.9%N/A0.2 $0.14 11/15/202253,600 shares $8,522.40 +51.8%N/A0.1 $0.16 10/31/202235,300 shares $4,465.45 -23.9%N/A0 $0.13The Real Reason Silver Prices Are Soaring (Ad)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.I'm offering a new 2025 Silver Wealth Guide and it is now available. 10/15/202246,400 shares $10,347.20 -95.6%N/A0.1 $0.22 9/30/20221,050,000 shares $283,815.00 +276.9%N/A1.7 $0.27 9/15/2022278,600 shares $105,589.40 +101.0%N/A0.5 $0.38 8/31/2022138,600 shares $95,744.88 +9.4%N/A2.4 $0.69 8/15/2022126,700 shares $150,773.00 -24.0%N/A2.7 $1.19 7/31/2022166,700 shares $206,708.00 -4.9%N/A3.7 $1.24 7/15/2022175,300 shares $194,583.00 +19.7%N/A3.9 $1.11 6/30/2022146,400 shares $96,638.64 -4.6%N/A3.1 $0.66 6/15/2022153,500 shares $193,410.00 +1.2%N/A4.4 $1.26 5/31/2022151,700 shares $227,550.00 +31.0%N/A8.6 $1.50 5/15/2022115,800 shares $185,534.76 -18.6%N/A4.1 $1.60 4/30/2022142,200 shares $251,694.00 -14.3%N/A4.3 $1.77 4/15/2022165,900 shares $328,482.00 +3.3%N/A4.5 $1.98 3/31/2022160,600 shares $338,866.00 +9.9%N/A4.3 $2.11 3/15/2022146,200 shares $248,540.00 -15.3%N/A3.2 $1.70 2/28/2022172,600 shares $336,570.00 +21.8%N/A3.3 $1.95 2/15/2022141,700 shares $317,408.00 -18.1%N/A2.4 $2.24 1/31/2022173,100 shares $368,703.00 -6.2%N/A3.1 $2.13 1/15/2022184,600 shares $304,590.00 -17.7%N/A3.3 $1.65 12/31/2021224,200 shares $387,888.42 +18.9%N/A4.1 $1.73 12/15/2021188,600 shares $330,050.00 -10.6%N/A3.7 $1.75 11/30/2021211,000 shares $390,350.00 +5.3%N/A4.1 $1.85 11/15/2021200,300 shares $426,639.00 -0.7%N/A3.5 $2.13 10/29/2021201,800 shares $431,852.00 -1.5%N/A3.6 $2.14 10/15/2021204,900 shares $405,702.00 +5.2%N/A1.6 $1.98 9/30/2021194,800 shares $422,716.00 -9.4%N/A1.3 $2.17 9/15/2021214,900 shares $472,780.00 -2.5%N/A0.9 $2.20 8/31/2021220,500 shares $500,535.00 -14.7%N/A0.9 $2.27 8/13/2021258,400 shares $607,240.00 +5.7%N/A1.1 $2.35 7/30/2021244,400 shares $615,888.00 +12.5%N/A1 $2.52 7/15/2021217,200 shares $562,548.00 -35.5%N/A1.3 $2.59 6/30/2021336,500 shares $952,295.00 +85.2%N/A2.1 $2.83 6/15/2021181,700 shares $675,924.00 -6.2%2.2%2.7 $3.72 5/28/2021193,800 shares $813,960.00 +6.9%2.3%3 $4.20 5/14/2021181,300 shares $692,566.00 -14.0%2.2%3.2 $3.82 4/30/2021210,900 shares $982,794.00 +18.2%2.5%1.8 $4.66 4/15/2021178,400 shares $713,600.00 -5.2%2.1%1.1 $4.00 3/31/2021188,100 shares $769,329.00 -3.9%2.3%1.2 $4.09 3/15/2021195,700 shares $884,564.00 +16.6%2.4%1.2 $4.52 2/26/2021167,800 shares $739,998.00 -12.2%2.2%0.8 $4.41 2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38 1/29/2021138,100 shares $760,240.50 +78.9%1.8%0.9 $5.51 1/15/202177,200 shares $633,040.00 No Change1.0%0.8 $8.20 PBLA Short Interest - Frequently Asked Questions What is Panbela Therapeutics' current short interest? Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 100 shares of PBLA short. Learn More on Panbela Therapeutics' current short interest. Is Panbela Therapeutics' short interest increasing or decreasing? Panbela Therapeutics saw a decline in short interest in May. As of May 15th, there was short interest totaling 100 shares, a decline of 93.8% from the previous total of 1,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Panbela Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Panbela Therapeutics: Alaunos Therapeutics, Inc. (4.39%), CERo Therapeutics Holdings, Inc. (11.96%), Titan Pharmaceuticals, Inc. (1.27%), IM Cannabis Corp. (0.87%), Mustang Bio, Inc. (1.87%), Galecto, Inc. (4.86%), Clearmind Medicine Inc. (5.50%), PainReform Ltd. (12.29%), Palisade Bio, Inc. (3.68%), Lixte Biotechnology Holdings, Inc. (1.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Panbela Therapeutics stock? Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. PBLA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Panbela Therapeutics? A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further. How often is Panbela Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Alaunos Therapeutics Short Interest Data CERo Therapeutics Short Interest Data Titan Pharmaceuticals Short Interest Data IM Cannabis Short Interest Data Mustang Bio Short Interest Data Galecto Short Interest Data Clearmind Medicine Short Interest Data PainReform Short Interest Data Palisade Bio Short Interest Data Lixte Biotechnology Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBLA) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBLA Stock Free PBLA Stock Alerts